BPTH Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: BPTH Shares Outstanding History and BPTH YTD Return |
BPTH Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: BPTH Shares Outstanding History and BPTH YTD Return |
BPTH Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-23.20% CAGR Mouse over chart for data details
|
BPTH Stock Price Chart |
About Bio-Path Holdings Inc |
Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, which targets growth factor receptor-bound protein 2, initially started the efficacy portion of a Phase 2 clinical trial for untreated acute myeloid leukemia patients. Co.'s second drug candidate, Liposomal Bcl-2, targets the protein Bcl-2, which is responsible for driving cell survival in up to 60% of all cancers. Co.'s third drug candidate, Liposomal STAT3, targets the STAT3 protein. We show 28 historical shares outstanding datapoints in our BPTH shares outstanding history coverage, used to compute BPTH market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BPTH market cap history over the course of time is important for investors interested in comparing BPTH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BPTH versus a peer is one thing; comparing BPTH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BPTH can fluctuate over the course of history. With this page we aim to empower investors researching BPTH by allowing them to research the BPTH market cap history. |
BPTH Current Stock Quote |
Free BPTH Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
BPTH Share Performance |
Market Cap Peers |
Bio-Path Holdings (BPTH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BRKR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.